Literature DB >> 33717081

Biomechanics of T Cell Dysfunctions in Chronic Diseases.

Sachith D Gunasinghe1,2, Newton G Peres1,2, Jesse Goyette1,2, Katharina Gaus1,2.   

Abstract

Understanding the mechanisms behind T cell dysfunctions during chronic diseases is critical in developing effective immunotherapies. As demonstrated by several animal models and human studies, T cell dysfunctions are induced during chronic diseases, spanning from infections to cancer. Although factors governing the onset and the extent of the functional impairment of T cells can differ during infections and cancer, most dysfunctional phenotypes share common phenotypic traits in their immune receptor and biophysical landscape. Through the latest developments in biophysical techniques applied to explore cell membrane and receptor-ligand dynamics, we are able to dissect and gain further insights into the driving mechanisms behind T cell dysfunctions. These insights may prove useful in developing immunotherapies aimed at reinvigorating our immune system to fight off infections and malignancies more effectively. The recent success with checkpoint inhibitors in treating cancer opens new avenues to develop more effective, targeted immunotherapies. Here, we highlight the studies focused on the transformation of the biophysical landscape during infections and cancer, and how T cell biomechanics shaped the immunopathology associated with chronic diseases.
Copyright © 2021 Gunasinghe, Peres, Goyette and Gaus.

Entities:  

Keywords:  T cell dysfunction; biomechanics; biophysical landscape; cancer; chronic diseases; immune receptor landscape; infections; tumor microenvironment

Year:  2021        PMID: 33717081      PMCID: PMC7948521          DOI: 10.3389/fimmu.2021.600829

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  337 in total

1.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.

Authors:  Ngozi Monu; Alan B Frey
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

Review 2.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 3.  Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.

Authors:  Mark J Smyth; Gavin P Dunn; Robert D Schreiber
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 4.  Cytokines and the inception of CD8 T cell responses.

Authors:  Maureen A Cox; Laurie E Harrington; Allan J Zajac
Journal:  Trends Immunol       Date:  2011-03-02       Impact factor: 16.687

Review 5.  Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Authors:  Anna Haas; Kathrin Zimmermann; Annette Oxenius
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

6.  Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.

Authors:  Alan G Ramsay; Andrew J Clear; Rewas Fatah; John G Gribben
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

7.  Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse.

Authors:  Maria Isabel Thoulouze; Nathalie Sol-Foulon; Fabien Blanchet; Alice Dautry-Varsat; Olivier Schwartz; Andrés Alcover
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

8.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

9.  Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.

Authors:  Jinsung Hong; Stephen P Persaud; Stephen Horvath; Paul M Allen; Brian D Evavold; Cheng Zhu
Journal:  J Immunol       Date:  2015-09-02       Impact factor: 5.422

Review 10.  T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Authors:  Jennifer D Stone; Adam S Chervin; David M Kranz
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

View more
  2 in total

1.  Immune Checkpoints Expression in Chronic Lung Allograft Rejection.

Authors:  Ilaria Righi; Valentina Vaira; Letizia Corinna Morlacchi; Giorgio Alberto Croci; Valeria Rossetti; Francesco Blasi; Stefano Ferrero; Mario Nosotti; Lorenzo Rosso; Mario Clerici
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

2.  Alterations of the 70 kDa heat shock protein (HSP70) and sequestosome-1 (p62) in women with breast cancer.

Authors:  Theofano Orfanelli; Spyridon Giannopoulos; Eleni Zografos; Aikaterini Athanasiou; Ann Marie Bongiovanni; Georgios Doulaveris; Tracy-Ann Moo; Dayle LaPolla; Chris N Bakoyiannis; Georgios E Theodoropoulos; Georgios C Zografos; Eleni Andreopoulou; Steven S Witkin
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.